Back to News >

---

A symposium discussing COVID-19 research, clinical trials and vaccine manufacturing in the Tees Valley and how we can prepare for the future.

About this Event

12.00pm Welcome Professor Vikki Rand (Head of Research, National Horizons Centre, Teesside University)

Followed by the Keynote Speaker: Steve Bagshaw, CBE

Vaccine development in the UK and the vaccines taskforce – the role Teesside has played in the full supply chain and lessons for the future

12.50-1.50pm Session 1:

Clinical Trials (Chair: Mr Paul Baker, Director for Research and Innovation, South Tees Hospitals NHS Foundation Trust)

Introduction to DTVRA and Clinical trials – Dr Jane Greenaway, Associate Director, Durham Tees Valley Research Alliance (DTVRA)

The REMAP CAP Trial – Professor Steve Bonner, Clinical Director & Research Director Critical Care, South Tees Hospitals NHS Foundation Trust

The CHOIS Study and Novavax Trial – Mr David Chadwick, Novavax Principal Investigator, DTVRA and Clinical Director in Urology, South Tees Hospitals NHS Foundation Trust

The RECOVERY Trial – Dr Ben Prudon, Respiratory Consultant, North Tees and Hartlepool NHS Foundation Trust

GENOMICC – Steven Liggett, Pathology Research & Development Facilitator, South Tees Hospitals NHS Foundation Trust

Q&A Session

1.50-2.30pm Session 2: Clinical Challenges and Research (Chair: Professor Vikki Rand)

The clinical experience of the First Wave of COVID-19 at Darlington Memorial Hospital: The DarCoVE Study – Professor Anjan Dhar, County Durham & Darlington NHS Foundation Trust

Clinical factors associated with mortality from COVID-19 in the UK and the North East: Lessons from the first wave of the pandemic – Dr Alex Newman, National Horizons Centre, Teesside University

Understanding the impact of the COVID-19 pandemic on wellbeing and physical activity behaviours of people in the North East of England – Drs Emma Giles and Alison Innerd, Centre for Public Health, Teesside University

Q & A Session

2.30-3.30pm Sessions 3: Vaccine Manufacture and the Future

Introduction (vaccine manufacturing, skills, facilities in our region and the UK ecosystem)

Challenges of vaccine manufacturing during a pandemic – Ken Holbourn FUJIFILM Diosynth Biotechnologies, Billingham

mRNA COVID-19 vaccine manufacturing and development of the mRNA vaccine library – John Liddell, Centre for Process Innovation (CPI), Darlington Central Park

Future – skills, partnerships and research (DTVRA, NBioP) – Dr Jen Vanderhoven, National Horizons Centre, Teesside University

---

Full details here.